V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20193528 | 20124322 | 1.7 | 81 | null | 2017-07-01 | 2017-08-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101216037 |
| 20193546 | 20124323 | 1.91 | 65.2 | Palliative (P) | 2017-05-20 | 2017-05-21 | Docetaxel | 02 | null | DOCETAXEL | 101693111 |
| 20193549 | 20124324 | 1.88 | 53.2 | Palliative (P) | 2019-02-15 | 2019-02-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101656525 |
| 20193551 | 20124325 | 1.69 | 65.8 | Palliative (P) | 2018-07-19 | 2018-07-19 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100896921 |
| 20193552 | 20124326 | 1.49 | 71.6 | Palliative (P) | 2020-11-12 | 2020-11-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100636346 |
| 20193561 | 20124327 | 1.67 | 84 | null | 2020-02-04 | 2020-02-05 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100579609 |
| 20193562 | 20124328 | 1.67 | 78 | Palliative (P) | 2017-11-11 | 2017-11-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101606832 |
| 20193564 | 20124329 | 1.6 | 40.5 | Palliative (P) | 2021-03-05 | 2021-07-27 | Docetaxel | 02 | N | DOCETAXEL | 100225701 |
| 20193566 | 20124330 | 1.7 | 88.2 | Palliative (P) | 2019-09-21 | 2019-10-05 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101616158 |
| 20193568 | 20124331 | 1.65 | 86.4 | null | 2019-10-24 | 2019-12-19 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | DOCETAXEL | 100289115 |
| 20193571 | 20124332 | 1.7 | 108.2 | Palliative (P) | 2019-12-20 | 2019-12-20 | Docetaxel | 02 | N | DOCETAXEL | 101208081 |
| 20193572 | 20124333 | 1.76 | 87.8 | 03 | 2020-06-13 | 2020-06-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101598457 |
| 20193575 | 20124334 | 1.7 | 71.05 | Palliative (P) | 2016-07-27 | 2016-08-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101650320 |
| 20193584 | 20124335 | 0 | 68.8 | null | 2017-06-17 | 2017-07-22 | Docetaxel | N | null | DOCETAXEL | 101001607 |
| 20193585 | 20124336 | 1.69 | 60.1 | Palliative (P) | 2018-04-03 | 2018-04-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101259055 |
| 20193591 | 20124337 | 1.67 | 61.8 | null | 2016-05-28 | 2016-09-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101414094 |
| 20193596 | 20124338 | 1.68 | 86 | null | 2019-11-27 | 2019-11-27 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101355009 |
| 20193600 | 20124339 | 1.82 | 68.3 | Palliative (P) | 2017-03-03 | 2017-08-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101591213 |
| 20193601 | 20124340 | 1.59 | 103.1 | Palliative (P) | 2017-05-27 | 2017-06-19 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101106963 |
| 20193607 | 20124341 | 1.7 | 87.9 | Palliative (P) | null | 2019-10-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100178906 |
| 20193611 | 20124342 | 1.69 | 64.1 | Palliative (P) | 2018-03-23 | 2018-07-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101232961 |
| 20193612 | 20124343 | 1.61 | 66.45 | Palliative (P) | 2020-02-09 | 2020-02-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101278506 |
| 20193613 | 20124344 | 1.67 | 59.9 | Palliative (P) | 2019-12-28 | 2020-01-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100617600 |
| 20193614 | 20124345 | 1.66 | 79.8 | Palliative (P) | 2018-02-07 | 2018-02-07 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101677561 |
| 20193615 | 20124346 | 1.66 | 81.2 | Palliative (P) | 2016-05-13 | 2016-05-30 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100593004 |
| 20193617 | 20124347 | 1.9 | 65.8 | null | 2018-02-10 | 2018-03-01 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101182409 |
| 20193619 | 20124348 | 1.51 | 57.7 | Palliative (P) | 2018-08-27 | 2019-05-22 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101540206 |
| 20193620 | 20124349 | 1.63 | 68.7 | null | 2017-10-03 | 2018-01-29 | Docetaxel | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101766082 |
| 20193622 | 20124350 | 1.7 | 72 | Palliative (P) | 2018-06-20 | 2018-06-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100447701 |
| 20193624 | 20124351 | 1.85 | 86.4 | Palliative (P) | 2017-06-06 | 2017-06-12 | Docetaxel | 02 | N | DOCETAXEL | 100762112 |
| 20193629 | 20124352 | 1.98 | 88.3 | Palliative (P) | 2020-01-15 | 2020-02-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100175707 |
| 20193631 | 20124353 | 1.67 | 106.5 | Adjuvant (A) | 2015-06-04 | 2017-05-13 | CETUXIMAB + IRINOTECAN + MDG | 01 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100783086 |
| 20193635 | 20124354 | 1.78 | 89.3 | Neo-adjuvant (N) | 2018-12-06 | 2018-12-13 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101303805 |
| 20193637 | 20124355 | 1.62 | 74.6 | Curative (C) | 2018-05-17 | 2018-05-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100672953 |
| 20193642 | 20124356 | 0 | 86.6 | Palliative (P) | 2018-03-26 | 2018-04-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101656994 |
| 20193646 | 20124357 | 1.79 | 0 | Palliative (P) | 2017-05-18 | 2017-05-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100319232 |
| 20193649 | 20124358 | 1.75 | 59.4 | Curative (C) | null | null | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101368656 |
| 20193650 | 20124359 | 1.7 | 52 | null | 2020-06-19 | 2020-06-26 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100513123 |
| 20193652 | 20124360 | 1.61 | 61.35 | Palliative (P) | 2018-11-19 | 2020-03-10 | Docetaxel | 02 | N | DOCETAXEL | 100783456 |
| 20193656 | 20124361 | 1.74 | 51.8 | Palliative (P) | 2019-08-21 | 2019-08-21 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100332272 |
| 20193658 | 20124362 | 1.7 | 56.2 | null | 2018-10-07 | 2018-10-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101833223 |
| 20193661 | 20124363 | 1.84 | 68.8 | Palliative (P) | 2016-10-22 | 2017-05-13 | Docetaxel | 02 | N | DOCETAXEL | 100037858 |
| 20193664 | 20124364 | 1.63 | 71.4 | 03 | 2021-01-10 | 2021-01-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100264360 |
| 20193669 | 20124365 | 1.3 | 97 | null | 2020-10-29 | 2020-10-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101035809 |
| 20193677 | 20124366 | 1.69 | 54.5 | null | 2017-11-04 | 2017-11-11 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100906015 |
| 20193683 | 20124367 | 1.79 | 75.4 | Adjuvant (A) | 2019-12-06 | 2019-12-09 | Docetaxel | N | N | DOCETAXEL | 101540372 |
| 20193692 | 20124368 | 1.82 | 70 | null | 2019-06-16 | 2019-12-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101254198 |
| 20193695 | 20124369 | 1.66 | 66 | Palliative (P) | 2020-08-01 | 2020-08-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101668432 |
| 20193697 | 20124370 | 1.66 | 108.2 | Palliative (P) | 2017-11-11 | 2017-11-11 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100967015 |
| 20193699 | 20124371 | 1.72 | 69 | Palliative (P) | 2016-05-01 | 2016-05-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100574318 |